[Oireachtas] Dáil Éireann debate. Question 970 – Medicinal products. [pregabalin-related deaths] [40177/23]. (20 Sep 2023)
Preview | Title | Contact |
---|---|---|
|
PDF (Response from the HSE)
435kB |
External website: https://www.oireachtas.ie/en/debates/question/2023...
- Deputy Róisín Shortall asked the Minister for Health his views on the number of pregabalin-related deaths between 2012 and 2020, as reported by the Health Research Board (details supplied); the actions he intends to take to address the substantial rise in pregabalin-related deaths; if he intends to curtail the source of pregabalin; and if he will make a statement on the matter. [40177/23]
Minister of State at the Department of Health: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible
Item Type
Dail Debates
Publication Type
Irish-related
Drug Type
New psychoactive substance
Intervention Type
Policy
Source
Date
20 September 2023
EndNote
Subjects
B Substances > New (novel) psychoactive substances > Other novel substances > Gabapentinoids GABA (Pregabalin / Gabapentin)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > Europe > Ireland
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page